Finance
Diagnostic device developer announces first quarter 2005 results
Published in Health and Medicine Week, May 23rd, 2005
For the first quarter of 2005, Inverness Medical Innovations reported an adjusted cash basis net loss of $3.8 million or $0.18 per share, after a charge of $4.25 million or $0.20 per diluted share related to its previously disclosed legal settlement with Princeton BioMeditech Corporation, compared to adjusted cash basis net income of $1.6 million or $0.08 per diluted share in the first quarter of 2004.
The net loss available to common stockholders prepared in accordance with accounting principles generally accepted in the United States of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Breast Cancer
Physical changes wrought by surgery may spur breast tumor metastasis - Contraception
Contraceptive vaccines reviewed - Gulf War Syndrome
Possible causes of Gulf War syndrome reviewed - Muscle Infarction
Diabetic muscle infarction reviewed - Obesity Therapy
Report of Mayo Clinic National Summit on obesity released - Acute Care
Different consultants mean different lengths of stay in hospitals - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
